Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention (Q38905356)

7 September 2017

Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention (English)

1 reference

7 September 2017

0 references

2

1 reference

7 September 2017

Martin Bergstrand

1

0 references

Nicholas John White

series ordinal

5

object named as

Nicholas J White

1 reference

7 September 2017

6

Joel Tarning

1 reference

7 September 2017

3

Khin Maung Lwin

1 reference

7 September 2017

4

Mats O Karlsson

1 reference

PubMed ID

25355697

7 September 2017

language of work or name

English

0 references

publication date

29 October 2014

1 reference

Science Translational Medicine

7 September 2017

1 reference

7 September 2017

6

1 reference

7 September 2017

260ra147

1 reference

7 September 2017

260

1 reference

Intermittent preventive treatment against malaria: an update

7 September 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

Intermittent presumptive treatment for malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: implications for prevention programmes in Plasmodium falciparum-endemic sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

Antimalarial dosing regimens and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

Efficacy, safety, and tolerability of three regimens for prevention of malaria: a randomized, placebo-controlled trial in Ugandan schoolchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

Pharmacometrics: modelling and simulation tools to improve decision making in clinical drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

Quantitative disease, drug, and trial models

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

Pharmacokinetics and bioequivalence evaluation of two fixed-dose tablet formulations of dihydroartemisinin and piperaquine in Vietnamese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

Pharmacokinetics and ex vivo pharmacodynamic antimalarial activity of dihydroartemisinin-piperaquine in patients with uncomplicated falciparum malaria in Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

Epidemiology of Malaria in Thailand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

The dynamics of naturally acquired immunity to Plasmodium falciparum infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

Piperaquine resistance is associated with a copy number variation on chromosome 5 in drug-pressured Plasmodium falciparum parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of piperaquine in plasma stable isotope labeled internal standard does not always compensate for matrix effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

Use of prior information to stabilize a population data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

Handling data below the limit of quantification in mixed effect models

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

The use of mixture models for the analysis of survival data with long-term survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005311

10.1126/SCITRANSLMED.3005311

21 January 2018

Identifiers

DOI

1 reference

7 September 2017

1 reference

PubMed ID

25355697